Department of Neurology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Section of Cardiology, Department of Internal Medicine, University of Chicago, Chicago, IL, United States.
Handb Clin Neurol. 2021;177:211-220. doi: 10.1016/B978-0-12-819814-8.00019-6.
Technologies for repairing cardiac structures or sustaining cardiac function with implantable devices have helped patients with an ever-expanding array of cardiac conditions. Patients are surviving and thriving with cardiac conditions that would formerly have been disabling or fatal. With the implantation of devices in the heart, however, comes the inevitable risk of neurological complications. This chapter focuses on devices implanted in the chambers or valves of the heart itself, including prosthetic heart valves, closure devices for patent foramen ovale, atrial appendage occluder devices, short-term implantable circulatory assist devices, and long-term ventricular assist devices, but excluding coronary artery stents or extracardiac devices. Further, it considers the procedural and postprocedural risks of the devices, leaving the discussion of clinical effectiveness of the devices to other chapters of this book.
植入式设备修复心脏结构或维持心脏功能的技术已经帮助患有各种心脏疾病的患者。以前可能导致残疾或致命的心脏疾病，现在患者也可以存活并康复。然而，随着心脏设备的植入，不可避免地会出现神经并发症的风险。本章重点介绍植入心脏腔室或瓣膜的设备，包括人工心脏瓣膜、卵圆孔未闭封堵器、心房附壁血栓封堵器、短期植入式循环辅助设备和长期心室辅助设备，但不包括冠状动脉支架或心脏外设备。此外，它还考虑了设备的手术和术后风险，将设备的临床效果的讨论留给本书的其他章节。
